查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1858698

人类纤维蛋白原：全球市占率排名、总销售额和需求预测（2025-2031年）

Human Fibrinogen - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 93 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024年全球人类纤维蛋白原市场规模估计为12.59亿美元，预计到2031年将达到25.62亿美元，在2025-2031年的预测期内，复合年增长率为10.5%。

本研究报告全面评估了人类纤维蛋白原的跨境产业布局、资本配置模式、区域经济相互依存关係，以及近期关税调整和国际供应链重组策略措施。

人类纤维蛋白原是一种高度纯化的血浆蛋白製剂，来自人类血浆（主要成分为纤维蛋白原），或透过重组技术生产。纤维蛋白原在血液凝固过程中起着关键作用，它经凝血酶转化为纤维蛋白，形成血块以止血。纤维蛋白原浓缩物主要用于治疗先天性或后天性纤维蛋白原缺乏症，控製手术或创伤期间的出血，以及其他需要快速补充纤维蛋白原的情况。

纤维蛋白原浓缩物市场的主要驱动因素是出血性疾病和需要快速止血的外科手术的日益增多，以及人们对标靶血液管理疗法的认识和应用不断提高。血浆分馏和重组技术的进步，以及对更安全、无病原体和高纯度血液製品的需求不断增长，也推动了市场成长。此外，人口老化、创伤和心血管手术发生率的上升，以及新兴地区医疗基础设施的持续改善，也促进了对纤维蛋白原浓缩物需求的成长。

主要企业包括CSL Behring、LFB集团、上海瑞斯血液製品有限公司、江西博亚生物製药有限公司和绿十字生物製品有限公司。前五名生产商占据了全球约90%的市场。亚太地区是最大的消费市场，约占60%，其次是美洲和欧洲，两者总合占30%以上。依产品类型划分，人纤维蛋白原浓缩物是最大的细分市场，占超过99%的市场。按应用领域划分，外科手术是最大的应用领域。

本报告旨在全面概述全球人类纤维蛋白原市场，重点关注总销售量、销售收入、价格、主要企业份额和排名，并按地区、国家、类型和应用进行分析。

本报告提供2020年至2031年人类纤维蛋白原市场规模、估算和预测的历史数据和预测数据，数据涵盖销售量（公斤）和销售收入，并以2024年为基准年。定量和定性分析有助于读者制定业务/成长策略、评估市场竞争格局、分析公司在当前市场中的地位，并就人类纤维蛋白原做出明智的商业决策。

目录

第一章 市场概览

  • 人类纤维蛋白原产品简介
  • 全球人类纤维蛋白原市场规模预测
  • 人类纤维蛋白原市场趋势及驱动因素
  • 先决条件和限制
  • 调查目的
  • 目标年份

第二章 公司竞争分析

  • 全球人类纤维蛋白原公司收入排名（2024 年）
  • 全球各公司人类纤维蛋白原收入（2020-2025 年）
  • 全球人类纤维蛋白原销售量排名（2024 年）
  • 全球各公司人类纤维蛋白原销售量（2020-2025 年）
  • 全球各公司人类纤维蛋白原平均价格（2020-2025 年）
  • 主要人类纤维蛋白原生产商的製造地和总部分布状况
  • 主要製造商提供的人类纤维蛋白原产品
  • 大型生产商何时开始大规模生产人类纤维蛋白原？
  • 人类纤维蛋白原市场竞争分析
  • 併购、扩张

第三章 依类型细分

  • 按类型介绍
    • 人类纤维蛋白原浓缩物
    • 动物纤维蛋白原浓缩物
  • 全球人类纤维蛋白原销售额（按类型划分）
  • 全球人类纤维蛋白原销售量（按类型划分）
  • 全球各类人类纤维蛋白原平均价格（2020-2031 年）

第四章 按应用进行细分

  • 透过申请
    • 先天性纤维蛋白原缺乏症
    • 外科手术
    • 其他的
  • 全球人类纤维蛋白原按应用领域分列的销售额
  • 全球人类纤维蛋白原销售量）
  • 全球平均人类纤维蛋白原价格（按用途划分）（2020-2031 年）

第五章 区域细分

  • 全球人类纤维蛋白原销售额（按地区划分）
  • 全球人类纤维蛋白原销售量（按地区划分）
  • 全球各地区平均人类纤维蛋白原价格（2020-2031 年）
  • 北美洲
  • 欧洲
  • 亚太地区
  • 南美洲
  • 中东和非洲

第六章 按主要国家和地区划分

  • 主要国家/地区人纤维蛋白原销售额成长趋势（2020 年 vs. 2024 年 vs. 2031 年）
  • 主要国家的人类纤维蛋白原销售额和销量
  • 美国
  • 欧洲
  • 中国
  • 日本
  • 韩国
  • 东南亚
  • 印度

第七章 公司简介

  • CSL Behring
  • LFB Group
  • Shanghai RAAS Blood Products
  • China Resources Boya Bio-pharmaceutical
  • Hualan Biological Engineering
  • Harbin Pacific Biopharmaceutical
  • China Meheco Group
  • Octapharma

第八章：产业链分析

第九章 研究结果与结论

第十章附录

The global market for Human Fibrinogen was estimated to be worth US$ 1259 million in 2024 and is forecast to a readjusted size of US$ 2562 million by 2031 with a CAGR of 10.5% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Human Fibrinogen cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Human Fibrinogen is a high-purity plasma protein preparation derived from human plasma or produced through recombinant technology, with fibrinogen as its main component. It plays a crucial role in blood clotting, as fibrinogen is converted into fibrin by thrombin to form a blood clot and stop bleeding. Fibrinogen concentrate is primarily used to treat congenital or acquired fibrinogen deficiencies, manage bleeding during surgery or trauma, and address other conditions requiring rapid fibrinogen supplementation.

The market for fibrinogen concentrate is primarily driven by the increasing prevalence of bleeding disorders and surgical procedures that require rapid hemostasis, as well as growing awareness and adoption of targeted blood management therapies. Advances in plasma fractionation and recombinant technologies, along with rising demand for safer, pathogen-reduced, and high-purity blood products, are also fueling market growth. Additionally, an aging population, higher incidence of trauma and cardiovascular surgeries, and expansion of healthcare infrastructure in emerging regions contribute to the increasing demand for fibrinogen concentrate.

Global Human Fibrinogen key players include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, GREEN CROSS, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest consumption market, with a share about 60%, followed by Americas and Europe, total have a share over 30 percent. In terms of product, Human Fibrinogen Concentrate is the largest segment, with a share over 99%. And in terms of application, the largest application is Surgical Procedures.

This report aims to provide a comprehensive presentation of the global market for Human Fibrinogen, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Human Fibrinogen by region & country, by Type, and by Application.

The Human Fibrinogen market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Fibrinogen.

Market Segmentation

By Company

  • CSL Behring
  • LFB Group
  • Shanghai RAAS Blood Products
  • China Resources Boya Bio-pharmaceutical
  • Hualan Biological Engineering
  • Harbin Pacific Biopharmaceutical
  • China Meheco Group
  • Octapharma

Segment by Type

  • Human Fibrinogen Concentrate
  • Animal Fibrinogen Concentrate

Segment by Application

  • Congenital Fibrinogen Deficiency
  • Surgical Procedures
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Human Fibrinogen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Human Fibrinogen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Human Fibrinogen in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Human Fibrinogen Product Introduction
  • 1.2 Global Human Fibrinogen Market Size Forecast
    • 1.2.1 Global Human Fibrinogen Sales Value (2020-2031)
    • 1.2.2 Global Human Fibrinogen Sales Volume (2020-2031)
    • 1.2.3 Global Human Fibrinogen Sales Price (2020-2031)
  • 1.3 Human Fibrinogen Market Trends & Drivers
    • 1.3.1 Human Fibrinogen Industry Trends
    • 1.3.2 Human Fibrinogen Market Drivers & Opportunity
    • 1.3.3 Human Fibrinogen Market Challenges
    • 1.3.4 Human Fibrinogen Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Human Fibrinogen Players Revenue Ranking (2024)
  • 2.2 Global Human Fibrinogen Revenue by Company (2020-2025)
  • 2.3 Global Human Fibrinogen Players Sales Volume Ranking (2024)
  • 2.4 Global Human Fibrinogen Sales Volume by Company Players (2020-2025)
  • 2.5 Global Human Fibrinogen Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Human Fibrinogen Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Human Fibrinogen Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Human Fibrinogen
  • 2.9 Human Fibrinogen Market Competitive Analysis
    • 2.9.1 Human Fibrinogen Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Human Fibrinogen Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Fibrinogen as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Human Fibrinogen Concentrate
    • 3.1.2 Animal Fibrinogen Concentrate
  • 3.2 Global Human Fibrinogen Sales Value by Type
    • 3.2.1 Global Human Fibrinogen Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Human Fibrinogen Sales Value, by Type (2020-2031)
    • 3.2.3 Global Human Fibrinogen Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Human Fibrinogen Sales Volume by Type
    • 3.3.1 Global Human Fibrinogen Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Human Fibrinogen Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Human Fibrinogen Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Human Fibrinogen Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Congenital Fibrinogen Deficiency
    • 4.1.2 Surgical Procedures
    • 4.1.3 Others
  • 4.2 Global Human Fibrinogen Sales Value by Application
    • 4.2.1 Global Human Fibrinogen Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Human Fibrinogen Sales Value, by Application (2020-2031)
    • 4.2.3 Global Human Fibrinogen Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Human Fibrinogen Sales Volume by Application
    • 4.3.1 Global Human Fibrinogen Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Human Fibrinogen Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Human Fibrinogen Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Human Fibrinogen Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Human Fibrinogen Sales Value by Region
    • 5.1.1 Global Human Fibrinogen Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Human Fibrinogen Sales Value by Region (2020-2025)
    • 5.1.3 Global Human Fibrinogen Sales Value by Region (2026-2031)
    • 5.1.4 Global Human Fibrinogen Sales Value by Region (%), (2020-2031)
  • 5.2 Global Human Fibrinogen Sales Volume by Region
    • 5.2.1 Global Human Fibrinogen Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Human Fibrinogen Sales Volume by Region (2020-2025)
    • 5.2.3 Global Human Fibrinogen Sales Volume by Region (2026-2031)
    • 5.2.4 Global Human Fibrinogen Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Human Fibrinogen Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Human Fibrinogen Sales Value, 2020-2031
    • 5.4.2 North America Human Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Human Fibrinogen Sales Value, 2020-2031
    • 5.5.2 Europe Human Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Human Fibrinogen Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Human Fibrinogen Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Human Fibrinogen Sales Value, 2020-2031
    • 5.7.2 South America Human Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Human Fibrinogen Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Human Fibrinogen Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Human Fibrinogen Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Human Fibrinogen Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Human Fibrinogen Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Human Fibrinogen Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Human Fibrinogen Sales Value, 2020-2031
    • 6.3.2 United States Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Human Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Human Fibrinogen Sales Value, 2020-2031
    • 6.4.2 Europe Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Human Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Human Fibrinogen Sales Value, 2020-2031
    • 6.5.2 China Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Human Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Human Fibrinogen Sales Value, 2020-2031
    • 6.6.2 Japan Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Human Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Human Fibrinogen Sales Value, 2020-2031
    • 6.7.2 South Korea Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Human Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Human Fibrinogen Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Human Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Human Fibrinogen Sales Value, 2020-2031
    • 6.9.2 India Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Human Fibrinogen Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 CSL Behring
    • 7.1.1 CSL Behring Company Information
    • 7.1.2 CSL Behring Introduction and Business Overview
    • 7.1.3 CSL Behring Human Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 CSL Behring Human Fibrinogen Product Offerings
    • 7.1.5 CSL Behring Recent Development
  • 7.2 LFB Group
    • 7.2.1 LFB Group Company Information
    • 7.2.2 LFB Group Introduction and Business Overview
    • 7.2.3 LFB Group Human Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 LFB Group Human Fibrinogen Product Offerings
    • 7.2.5 LFB Group Recent Development
  • 7.3 Shanghai RAAS Blood Products
    • 7.3.1 Shanghai RAAS Blood Products Company Information
    • 7.3.2 Shanghai RAAS Blood Products Introduction and Business Overview
    • 7.3.3 Shanghai RAAS Blood Products Human Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Shanghai RAAS Blood Products Human Fibrinogen Product Offerings
    • 7.3.5 Shanghai RAAS Blood Products Recent Development
  • 7.4 China Resources Boya Bio-pharmaceutical
    • 7.4.1 China Resources Boya Bio-pharmaceutical Company Information
    • 7.4.2 China Resources Boya Bio-pharmaceutical Introduction and Business Overview
    • 7.4.3 China Resources Boya Bio-pharmaceutical Human Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 China Resources Boya Bio-pharmaceutical Human Fibrinogen Product Offerings
    • 7.4.5 China Resources Boya Bio-pharmaceutical Recent Development
  • 7.5 Hualan Biological Engineering
    • 7.5.1 Hualan Biological Engineering Company Information
    • 7.5.2 Hualan Biological Engineering Introduction and Business Overview
    • 7.5.3 Hualan Biological Engineering Human Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Hualan Biological Engineering Human Fibrinogen Product Offerings
    • 7.5.5 Hualan Biological Engineering Recent Development
  • 7.6 Harbin Pacific Biopharmaceutical
    • 7.6.1 Harbin Pacific Biopharmaceutical Company Information
    • 7.6.2 Harbin Pacific Biopharmaceutical Introduction and Business Overview
    • 7.6.3 Harbin Pacific Biopharmaceutical Human Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Harbin Pacific Biopharmaceutical Human Fibrinogen Product Offerings
    • 7.6.5 Harbin Pacific Biopharmaceutical Recent Development
  • 7.7 China Meheco Group
    • 7.7.1 China Meheco Group Company Information
    • 7.7.2 China Meheco Group Introduction and Business Overview
    • 7.7.3 China Meheco Group Human Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 China Meheco Group Human Fibrinogen Product Offerings
    • 7.7.5 China Meheco Group Recent Development
  • 7.8 Octapharma
    • 7.8.1 Octapharma Company Information
    • 7.8.2 Octapharma Introduction and Business Overview
    • 7.8.3 Octapharma Human Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Octapharma Human Fibrinogen Product Offerings
    • 7.8.5 Octapharma Recent Development

8 Industry Chain Analysis

  • 8.1 Human Fibrinogen Industrial Chain
  • 8.2 Human Fibrinogen Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Human Fibrinogen Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Human Fibrinogen Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Human Fibrinogen Market Trends
  • Table 2. Human Fibrinogen Market Drivers & Opportunity
  • Table 3. Human Fibrinogen Market Challenges
  • Table 4. Human Fibrinogen Market Restraints
  • Table 5. Global Human Fibrinogen Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Human Fibrinogen Revenue Market Share by Company (2020-2025)
  • Table 7. Global Human Fibrinogen Sales Volume by Company (2020-2025) & (Kg)
  • Table 8. Global Human Fibrinogen Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Human Fibrinogen Price by Company (2020-2025) & (USD/Kg)
  • Table 10. Key Manufacturers Human Fibrinogen Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Human Fibrinogen Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Human Fibrinogen
  • Table 13. Global Human Fibrinogen Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Fibrinogen as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Human Fibrinogen Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Human Fibrinogen Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Human Fibrinogen Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Human Fibrinogen Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Human Fibrinogen Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Human Fibrinogen Sales Volume by Type: 2020 VS 2024 VS 2031 (Kg)
  • Table 22. Global Human Fibrinogen Sales Volume by Type (2020-2025) & (Kg)
  • Table 23. Global Human Fibrinogen Sales Volume by Type (2026-2031) & (Kg)
  • Table 24. Global Human Fibrinogen Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Human Fibrinogen Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Human Fibrinogen Price by Type (2020-2025) & (USD/Kg)
  • Table 27. Global Human Fibrinogen Price by Type (2026-2031) & (USD/Kg)
  • Table 28. Global Human Fibrinogen Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Human Fibrinogen Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Human Fibrinogen Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Human Fibrinogen Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Human Fibrinogen Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Human Fibrinogen Sales Volume by Application: 2020 VS 2024 VS 2031 (Kg)
  • Table 34. Global Human Fibrinogen Sales Volume by Application (2020-2025) & (Kg)
  • Table 35. Global Human Fibrinogen Sales Volume by Application (2026-2031) & (Kg)
  • Table 36. Global Human Fibrinogen Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Human Fibrinogen Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Human Fibrinogen Price by Application (2020-2025) & (USD/Kg)
  • Table 39. Global Human Fibrinogen Price by Application (2026-2031) & (USD/Kg)
  • Table 40. Global Human Fibrinogen Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Human Fibrinogen Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Human Fibrinogen Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Human Fibrinogen Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Human Fibrinogen Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Human Fibrinogen Sales Volume by Region (Kg): 2020 VS 2024 VS 2031
  • Table 46. Global Human Fibrinogen Sales Volume by Region (2020-2025) & (Kg)
  • Table 47. Global Human Fibrinogen Sales Volume by Region (2026-2031) & (Kg)
  • Table 48. Global Human Fibrinogen Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Human Fibrinogen Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Human Fibrinogen Average Price by Region (2020-2025) & (USD/Kg)
  • Table 51. Global Human Fibrinogen Average Price by Region (2026-2031) & (USD/Kg)
  • Table 52. Key Countries/Regions Human Fibrinogen Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Human Fibrinogen Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Human Fibrinogen Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Human Fibrinogen Sales Volume, (2020-2025) & (Kg)
  • Table 56. Key Countries/Regions Human Fibrinogen Sales Volume, (2026-2031) & (Kg)
  • Table 57. CSL Behring Company Information
  • Table 58. CSL Behring Introduction and Business Overview
  • Table 59. CSL Behring Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 60. CSL Behring Human Fibrinogen Product Offerings
  • Table 61. CSL Behring Recent Development
  • Table 62. LFB Group Company Information
  • Table 63. LFB Group Introduction and Business Overview
  • Table 64. LFB Group Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 65. LFB Group Human Fibrinogen Product Offerings
  • Table 66. LFB Group Recent Development
  • Table 67. Shanghai RAAS Blood Products Company Information
  • Table 68. Shanghai RAAS Blood Products Introduction and Business Overview
  • Table 69. Shanghai RAAS Blood Products Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 70. Shanghai RAAS Blood Products Human Fibrinogen Product Offerings
  • Table 71. Shanghai RAAS Blood Products Recent Development
  • Table 72. China Resources Boya Bio-pharmaceutical Company Information
  • Table 73. China Resources Boya Bio-pharmaceutical Introduction and Business Overview
  • Table 74. China Resources Boya Bio-pharmaceutical Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 75. China Resources Boya Bio-pharmaceutical Human Fibrinogen Product Offerings
  • Table 76. China Resources Boya Bio-pharmaceutical Recent Development
  • Table 77. Hualan Biological Engineering Company Information
  • Table 78. Hualan Biological Engineering Introduction and Business Overview
  • Table 79. Hualan Biological Engineering Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 80. Hualan Biological Engineering Human Fibrinogen Product Offerings
  • Table 81. Hualan Biological Engineering Recent Development
  • Table 82. Harbin Pacific Biopharmaceutical Company Information
  • Table 83. Harbin Pacific Biopharmaceutical Introduction and Business Overview
  • Table 84. Harbin Pacific Biopharmaceutical Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 85. Harbin Pacific Biopharmaceutical Human Fibrinogen Product Offerings
  • Table 86. Harbin Pacific Biopharmaceutical Recent Development
  • Table 87. China Meheco Group Company Information
  • Table 88. China Meheco Group Introduction and Business Overview
  • Table 89. China Meheco Group Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 90. China Meheco Group Human Fibrinogen Product Offerings
  • Table 91. China Meheco Group Recent Development
  • Table 92. Octapharma Company Information
  • Table 93. Octapharma Introduction and Business Overview
  • Table 94. Octapharma Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
  • Table 95. Octapharma Human Fibrinogen Product Offerings
  • Table 96. Octapharma Recent Development
  • Table 97. Key Raw Materials Lists
  • Table 98. Raw Materials Key Suppliers Lists
  • Table 99. Human Fibrinogen Downstream Customers
  • Table 100. Human Fibrinogen Distributors List
  • Table 101. Research Programs/Design for This Report
  • Table 102. Key Data Information from Secondary Sources
  • Table 103. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Human Fibrinogen Product Picture
  • Figure 2. Global Human Fibrinogen Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Human Fibrinogen Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Human Fibrinogen Sales Volume (2020-2031) & (Kg)
  • Figure 5. Global Human Fibrinogen Sales Price (2020-2031) & (USD/Kg)
  • Figure 6. Human Fibrinogen Report Years Considered
  • Figure 7. Global Human Fibrinogen Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Human Fibrinogen Players Sales Volume Ranking (2024) & (Kg)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Fibrinogen Revenue in 2024
  • Figure 10. Human Fibrinogen Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Human Fibrinogen Concentrate Picture
  • Figure 12. Animal Fibrinogen Concentrate Picture
  • Figure 13. Global Human Fibrinogen Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Human Fibrinogen Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Human Fibrinogen Sales Volume by Type (2020 VS 2024 VS 2031) & (Kg)
  • Figure 16. Global Human Fibrinogen Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Human Fibrinogen Price by Type (2020-2031) & (USD/Kg)
  • Figure 18. Product Picture of Congenital Fibrinogen Deficiency
  • Figure 19. Product Picture of Surgical Procedures
  • Figure 20. Product Picture of Others
  • Figure 21. Global Human Fibrinogen Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Human Fibrinogen Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Human Fibrinogen Sales Volume by Application (2020 VS 2024 VS 2031) & (Kg)
  • Figure 24. Global Human Fibrinogen Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Human Fibrinogen Price by Application (2020-2031) & (USD/Kg)
  • Figure 26. North America Human Fibrinogen Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Human Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Human Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Human Fibrinogen Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Human Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Human Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Human Fibrinogen Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Human Fibrinogen Sales Volume (%), (2020-2031)
  • Figure 38. United States Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Human Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Human Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Human Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Human Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Human Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Human Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Human Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Human Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Human Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Human Fibrinogen Industrial Chain
  • Figure 60. Human Fibrinogen Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed